Traveler Diarrhea
📧 Sign up to get email alerts when something new happens for Traveler Diarrhea.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-30FDA Approved: ANTI DIARRHEAL — Supplemental Application (H E B)
FDA approved a supplemental application for an anti-diarrheal product containing loperamide HCl submitted by H E B, indicating regulatory ap…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea [Phase 3]
Phase 3 study evaluating prulifloxacin vs placebo for traveler's diarrhea has completed, reporting on safety and efficacy in adult travelers…
-
FDA approval · 2014-12-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim from Amneal Pharmaceuticals of New York LLC. The approval cove…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: LT Vaccine Patch Self-Administration Study [Phase 2]
Phase 2 trial update for a self-administered LT vaccine patch in preventing travelers' diarrhea; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch [Phase 2]
Phase 2 safety and immunogenicity study of a Traveler's Diarrhea vaccine patch completed with results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-03-12FDA Approved: XIFAXAN — Supplemental Application (Salix Pharmaceuticals, Inc.)
The FDA approved a supplemental application for XIFAXAN (rifaximin) filed by Salix Pharmaceuticals, Inc., resulting in an update to the prod…
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled study evaluating prevention of traveler's diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study [Phase 2]
Phase 2 Asia efficacy study of a Traveler's diarrhea vaccine by Intercell USA, Inc. has completed; this is a status update on the trial.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Probiotics and the Prevention of Traveler's Diarrhea [Phase 4]
Phase 4 clinical trial evaluating a probiotic formulation for prevention of traveler's diarrhea; study terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-21Clinical Trial Update: Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults [Phase 3]
Phase 3 trial evaluating BIO-K+ CL1285 Prophylaxis for preventing traveler's diarrhea in adults has completed; results are not detailed in t…
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea [Phase 4]
Phase 4 clinical trial evaluating rifaximin, loperamide, and their combination for traveler's diarrhea has completed.
-
FDA approval · 2007-10-23FDA Approved: GOOD NEIGHBOR PHARMACY ANTI DIARRHEAL — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Anti Diarrheal containing loperamide HCl, submitted by AmerisourceBer…
-
FDA label_change · 2007-06-05FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) to modify the labeling.
-
CLINICAL_TRIALS trial_result · 2007-02-15Clinical Trial Update: Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I [Phase 1]
Phase 1 trial evaluating the efficacy of anti-CFA/I and CfaE bovine milk immunoglobulin to prevent diarrhea after challenge with CFA/I-expre…
-
CLINICAL_TRIALS trial_result · 2006-05-09Clinical Trial Update: Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea [Phase 2]
Phase 2 trial evaluating rifaximin versus placebo for preventing traveler’s diarrhea has completed.